Crohn’s Disease

Crohn’s disease is a bowel disease which is inflammatory and causes severe burns in the bowel region. The IBD (which refers to Inflammatory Bowel diseases) causes disturbance to the ecosystem of the gut through increased immune responses that are inflammatory and painful.

Research by David FriedMan

People who hold this gene variant create low quantity of the enzyme which causes dampening of the inflammation, and is known as CD30. This can cause the immunity move towards IBD, as per the suggestions of the David Friedman, who is an MD at the Medical Center Beth Deaconess along with his research crew members.

As per their data it has been said that the gene variants by the name CD39 are closely linked with the bowel disease that is inflammatory and causes heavy pain in human beings and this has been concluded by the researchers. Their reports has appeared in the Proceeding from Natural Science Academies journal that was published during 29th, September 2009.

The researchers have fed some test mice with chemicals that produce IBD in these animals. Also the mice that were particularly bred in such a way as to be devoid of CD39 gene had worse inflammatory bowel problems than the mice that had the normal gene variant.

All the human beings have CD39 gene. But some hold the versions which are associated with lower levels of CD39. The scientist Friedman along with his colleagues has spotted out genetic markers for low production of CD39. They have looked for the gene marker in around Thousand Seven Hundred and Forty Eight patients who had crohn’s disease and also the same in around two thousand nine hundred and thirty six people who did not have IBD.

CD39 Levels and Its Impact

Also they discovered that genetic markers could be found commonly among people who had crohn’s disease. Also the people who did not have inflammatory bowel disease carried 2 copies of the CD39 gene while people who have crohn’s disease had the probability to contain 2 copies of this CD39 level low gene variants. Genetics are not the fate. Also not everybody with CD39 low level of gene will contain inflammatory bowel diseases. Even people who have 2 copies of this gene can have high risk of the crohn’s disease by twenty seven percent.

But since around forty percent of the European whites hold a minimum of 1 copy of this gene, the effects of this gene is spread across the complete population and has a big impact. Also, the gene can cause more than IBD and is also found to be associated with kidney diseases for people who contain diabetes as well blood coagulation in arteries. The researchers have decided to do further research on CD39 role in the IBD.

The scientists made use of Bacteroides Ovatus, which is contained by people usually in their gut, which they modified genetically for secreting a protein known as KGF-2 when they get exposed to xylan, a sugar. The thing is to raise the existence of KGF-2, which is growth factor that can help in healing the damages caused by bowel diseases that are inflammatory.

Why cannot we give the growth factors of humans directly? Since they are highly unstable when they are distributed orally and the administration systematically needs high dosage which could increase the danger behind unnecessary side effects. The researches have written in the online edition of the journal gut.

Effect of Xylan and Bacteria on Mice

Their research was focused especially on mice containing colitis, which is a category of inflammatory bowel disease. The scientists treated them with the genetically manufacture bacteria to the same mice orally every alternate day, and they braided their drinking water with xylan. For the sake of comparison of results, they did not get the rest of the mice, the bacteria or the xylan drink. When equated with other mice, the ones which got treatment with xylan drink and bacteria had a loss in rectal bleeding, weight loss and inflammation. They also had quicker healing of the tissue damaged with colitis, and also consistent improvement in their stool.

Results by Cardigan

The tests have to be done with human beings and one of the major researches, Mr. Simon Carding, had a discussion about this treatment through mails. He is a mucosal immunology professor at the University of England and he is the integrated biology director. He has stated that the bacteria that were used are usually present in human gut, so patients will have to be treated first for taking these bacteria which they have already and it should be tolerated by them.

The queries which are still not answered as the protocols for dosage, which is planned to be addressed after the studies are complete further. It could be possible for doing a 1 time bacteria dosage regimen which can establish an everlasting colony of such bacteria which are genetically cultivated. Another choice is establishing temporary colony by doing such treatments when flaring up of disease occurs again.

Carding has said that xylan’s natural sources are rice husks, oat kernels and tree barks which are not found in human diet usually. So, patients can complement their diet by taking xylan as a drink. Aninals can tolerate the high density of xylan in drinking water easily and did not exhibit any negative signs for excessive consumption of xylan as per Cardigan’s report.

Cardigan has stated the strategy of employing bacteria could be made use for treating gut diseases which includes the use of delivery agents for interfering with blood vessel formation to feed the tumors in intestine and for delivering the antigens against bacteria, infection and virus prevention.

It is mainly a disease of the intestine. Symptoms of Crohn’s disease are similar to another dysfunction which involves the swelling of the large intestine or colon also referred to as ulcerative colitis. Both the Crohn’s disease and ulcerative colitis together is frequently called as inflammatory bowel disease (IBD). Both Crohn’s disease and Ulcerative colitis is said to have no medical cure. At the initial stage that is during the onset of the disease they usually alternate between periods of activity (relapse) and inactivity (remission).

According to a research by a group of scientists of United States there are nearly 500,000 to two million people who are reported to be suffering from this disease and men and women are equally affected by this disease. Generally it is seen among children who have just crossed the adolescence or early adulthood but can also begin later in life.

Causes of Crohn’s Disease

Though many theories have been suggested by scientists for the causes of Crohn’s disease but still there is no proven fact about it. Many scientists suggest that one of the main causes of Crohn’s disease symptom is that body’s immune system which is made up of complex proteins and different sorts of cells that protects human beings from infections, reacts abnormally when it confronts with foods and other substances and thinks that they are foreign anti-bodies and try to invade these attackers, in this process, white blood cells line up and accumulate in the intestines producing swelling which causes ulcerations and injury to bowel movement and leads to great discomfort to the patients.

Symptoms of Crohn’s Disease

The first and foremost Symptoms of Crohn’s disease are abdominal pain, than comes diarrhea which nearly follows the abdominal pain, it causes especially those who have undergone surgery or multiple surgeries in the recent past. In the Crohn’s disease symptoms a diarrhea may or may not accompany along with with drops of blood. What kind of diarrhea a patient may suffer, mainly depends upon which part of the colon or small intestine is affected for example those suffering from Ileitis they pass large volume of watery faeces and those suffering from colitis they pass small amount of faeces but had to visit the toilet frequently.

Crohn’s Disease Treatment

The main Crohn’s disease treatment is medication to restrict the swelling of the intestine and to prevent pain and resume to normal activities of life. Corticosteroids or TNF antagonists is used to cure severe crohn’s disease. It is mainly given through veins that are these treatments are intravenous.